🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This study will evaluate the safety and effectiveness of micellar paclitaxe...
Status
Completed
Location
National Cancer Institute (NCI)
Start Date
2000-09
Trial ID
NCT00006276
Treatments Being Tested
RATIONALE: Paclitaxel is one of the most widely used human anticancer agent...
Status
Completed
Location
Gomel Regional Clincial Oncology Center
Start Date
2009-02
Trial ID
NCT00989131
To explore the efficiency and safety of Tislelizumab combinated with carbop...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2024-04-20
Trial ID
NCT06366945
The NCCN guidelines recommend induction chemotherapy followed by concurrent...
Status
Recruiting
Location
Sun Yat-sen University Cancer Center
Start Date
2024-03-19
Trial ID
NCT06301165
Treatments Being Tested
This trial is a multi-center, randomized, open, parallel-group and positive...
Status
Recruiting
Location
Jiangsu Province Hospital
Start Date
2025-02-05
Trial ID
NCT06752811
After the standard first-line treatment, the treatment regimen was adjusted...
Status
Active Not Recruiting
Location
Peking Union Medical College Hospital
Start Date
2024-08-07
Trial ID
NCT07159204
Treatments Being Tested
Moving immunotherapy ahead of chemoradiotherapy in a "sandwich" model-where...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2026-02
Trial ID
NCT07418866
Treatments Being Tested
Paxceed™ is being developed by Angiotech Pharmaceuticals, Inc. for the trea...
Status
Completed
Location
University of Alabama at Birmingham
Start Date
2002-09
Trial ID
NCT00055133
Treatments Being Tested
This is a prospective, single-arm, single-center, phaseⅡtrial to evaluate t...
Status
Unknown
Location
Jiangsu Cancer Institute & Hospital
Start Date
2023-03-15
Trial ID
NCT05782426
Treatments Being Tested